Proactive gliding-nanomachines declined tumor autophagy for enhanced tumor death
Source abstract
Abstract
Autophagy was associated with the pathophysiology of various diseases in vivo , and its own regulation was beneficial for the outcomes of specific diseases. Here, we successfully designed a biocompatible active gliding-nanomachine for delivery of chloroquine (CQ)/nanodiamond (ND) and accelerated tumor cell death associated with amplifying ferroptosis and declining autophagy in vitro . Fe was covered onto one side of the surface of the L-arg@CQ/ND@HA, functioning as a controller for the dominated release of NO by sensitive ROS and Fenton-reaction from the catalyzation between Fe 2+ and H 2 O 2 in vitro . The asymmetrical NO release, which was not only the active-component to decline tumor autophagy in combination with ND/CQ, but also the propellants for the nanomachines. After implementing in tumor cell, the dynamic-sliding of nanomachines could be triggered via ROS and the proactive-gliding further strengthened diffusion of CQ/ND, leading to precise-treatment of tumors through enlarging ferroptosis accompanied by polyamine output and interruption of autophagosome lysosome fusion. The synthetized dynamic sliding-nanomachines, with ROS stimulation of movement behavior and proactive delivery of CQ/ND unlocked huge latent capacity as a potential platform for tumor treatment stemed from ferroptosis amplification loop induced polyamine output and declining autophagy in tumor cell. Lin Zhang et al. developed a active gliding - nanomachine (Fe@L-arg@CQ/ND@HA) that could enhance tumor treatment by declining tumor autophagy and amplifying ferroptosis accompanied by polyamine output. These distinctive-nanomachines dramatically accelerated tumor cell death through chloroquine (CQ) synergism nanodiamond (ND). • Fe@L-arg@CQ/ND@HA-nanomachines executed gliding by asymmetric NO release. • Fe 2+ catalyzed H 2 O 2 to produce •OH via Fenton-reaction. • Fe 3+ overload mediated polyamine output to amplify ferroptosis. • Released NO restrained tumor autophagy in combination with CQ/ND.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Ferroptosis and cancer prognosis · Autophagy in Disease and Therapy
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (43)
Show source-provided references
1. Inhibiting cytoprotective autophagy in cancer therapy: an update on pharmacological small-molecule compounds
2. How autophagy controls the intestinal epithelial barrier10.1080/15548627.2021.1909406 ↗
3. Targeting autophagy in cancer10.1038/nrc.2017.53 ↗
4. The different autophagy degradation pathways and neurodegeneration10.1016/j.neuron.2022.01.017 ↗
5. Autophagy in the pathogenesis of disease10.1016/j.cell.2007.12.018 ↗
6. Nanodiamond autophagy inhibitor allosterically improves the arsenical-based therapy of solid tumors10.1038/s41467-018-06749-2 ↗
7. Self-delivery biomedicine for enhanced photodynamic therapy by feedback promotion of tumor autophagy10.1016/j.actbio.2022.12.059 ↗
8. Anthracycline-induced cardiotoxicity: causes, mechanisms, and prevention10.1007/978-3-030-43032-0_15 ↗
9. Checkpoint inhibitor hepatotoxicity: pathogenesis and management10.1097/HEP.0000000000000045 ↗
10. Toxicities associated with immune checkpoint inhibitors: a systematic study10.1097/JS9.0000000000000368 ↗
11. Review targeted drug delivery systems for norcantharidin in cancer therapy10.1186/s12951-022-01703-3 ↗
12. Delivery of MutT homolog 1 inhibitor by functionalized graphene oxide nanoparticles for enhanced chemo-photodynamic therapy triggers cell death in osteosarcoma10.1016/j.actbio.2020.04.009 ↗
13. Tailored chemodynamic nanomedicine improves pancreatic cancer treatment via controllable damaging neoplastic cells and reprogramming tumor microenvironment10.1021/acs.nanolett.0c02622 ↗
14. H2S-powered nanomotors for active therapy of tumors by inducing ferroptosis and lactate-pyruvate axis disorders10.1021/acsbiomaterials.3c01665 ↗
15. Noncontinuous super-diffusive dynamics of a light-activated nanobottle motor10.1002/anie.201801910 ↗
16. Biosafety, functionalities, and applications of biomedical micro/nanomotors10.1002/anie.202013689 ↗
17. How safe are magnetic nanomotors: from cells to animals10.1016/j.bioadv.2022.213048 ↗
18. Biomedical micro-/nanomotors: from overcoming biological barriers to in vivo imaging10.1002/adma.202000512 ↗
19. Arthritic microenvironment actuated nanomotors for active rheumatoid arthritis therapy
20. Recent progress of micro/nanomotors to overcome physiological barriers in the gastrointestinal tract10.1016/j.jconrel.2023.07.005 ↗
21. pH/ROS-responsive propelled nanomotors for the active treatment of renal injury10.1039/D3NR00062A ↗
22. Biomimetic and NOS-responsive nanomotor deeply delivery a combination of MSC-EV and mitochondrial ROS scavenger and promote heart repair and regeneration
23. Oral nanomotor-enabled mucus traverse and tumor penetration for targeted chemo-sono-immunotherapy against colon cancer10.1002/smll.202203466 ↗
24. Bio-inspired nitric-oxide-driven nanomotor10.1038/s41467-019-08670-8 ↗
25. Fenton reaction induced by fe-based nanoparticles for tumor therapy10.1166/jbn.2021.3130 ↗
26. Metal-polyphenol-network coated prussian blue nanoparticles for synergistic ferroptosis and apoptosis via triggered GPX4 inhibition and concurrent in situ bleomycin toxification10.1002/smll.202103919 ↗
27. Chloroquine and hydroxychloroquine in antitumor therapies based on autophagy-related mechanisms10.1016/j.phrs.2021.105582 ↗
28. In situ nitric oxide gas nanogenerator reprograms glioma immunosuppressive microenvironment
29. Polyamine-mediated ferroptosis amplification acts as a targetable vulnerability in cancer10.1038/s41467-024-46776-w ↗
30. Nanomachine-based flexible bubbles for alleviating long QT syndrome
31. Anisotropic truncated octahedral au with pt deposition on arris for localized surface plasmon resonance-enhanced photothermal and photodynamic therapy of osteosarcoma10.1021/acsami.1c07181 ↗
32. pH-responsive neutrophil membrane camouflage Ga-Mn bimetallic nanodecoy triggers apoptosis-immunity-metastasis suppression for tumor therapy10.1016/j.biomaterials.2025.123794 ↗
33. Active oxygen chemistry within the liposomal bilayer. Part IV: locating 2',7'-dichlorofluorescein (DCF), 2',7'-dichlorodihydrofluorescein (DCFH) and 2',7'-dichlorodihydrofluorescein diacetate (DCFH-DA) in the lipid bilayer10.1016/j.chemphyslip.2004.04.006 ↗
34. Gal3-CaN-smurf1 complex sequestrates FLCN-FNIPs to facilitate TFEB activation in response to endomembrane damage
35. Killing cancer cells by rupturing their lysosomes10.1038/s41565-020-0639-z ↗
36. Targeted crystallization of mixed-charge nanoparticles in lysosomes induces selective death of cancer cells10.1038/s41565-020-0643-3 ↗
37. Strategies for enhancing the heterogeneous fenton catalytic reactivity:a review10.1016/j.apcatb.2019.05.041 ↗
38. A strategy of fenton reaction cycloacceleration for high-performance ferroptosis therapy initiated by tumor microenvironment remodeling10.1002/adhm.202203362 ↗
39. The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions10.1016/j.ccell.2024.03.011 ↗
40. A diversity of selective autophagy receptors determines the specificity of the autophagy pathway10.1016/j.molcel.2019.09.005 ↗
41. MiR-3653 blocks autophagy to inhibit epithelial-mesenchymal transition in breast cancer cells by targeting the autophagy-regulatory genes ATG12 and AMBRA110.1097/CM9.0000000000002569 ↗
42. Aloperine suppresses cancer progression by interacting with VPS4A to inhibit autophagosome-lysosome fusion in NSCLC
43. The emerging potential role of p62 in cancer treatment by regulating metabolism10.1016/j.tem.2023.05.004 ↗